These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29084449)

  • 1. Editorial Comment on: Device-Related Adverse Events During Percutaneous Nephrolithotomy: Review of the Manufacturer and User Facility Device Experience Database by Patel et al. (From: Patel NH, Schulman AA, Bloom JB, et al. J Endourol 2017;31:1007-1011).
    Andonian S
    J Endourol; 2018 Jan; 32(1):73-74. PubMed ID: 29084449
    [No Abstract]   [Full Text] [Related]  

  • 2. Device-Related Adverse Events During Percutaneous Nephrolithotomy: Review of the Manufacturer and User Facility Device Experience Database.
    Patel NH; Schulman AA; Bloom JB; Uppaluri N; Phillips JL; Konno S; Choudhury M; Eshghi M
    J Endourol; 2017 Oct; 31(10):1007-1011. PubMed ID: 28830243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Comment on: Management of Colon Perforation During Percutaneous Nephrolithotomy: 12 Years of Experience in a Referral Center by Maghsoudi et al. (From: Maghsoudi R, Etemadian M, Kashi AH, et al. J Endourol 2017;31:1032-1036).
    Wolf JS
    J Endourol; 2017 Nov; 31(11):1215. PubMed ID: 29048221
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial Comment on: Randomized Controlled Trial Comparing Three Different Modalities of Lithotrites for Intracorporeal Lithotripsy in Percutaneous Nephrolithotomy by York et al. (From: York NE, Borofsky MS, Chew BH, et al. J Endourol 2017;31:1145-1151).
    Grasso M
    J Endourol; 2018 Jan; 32(1):75. PubMed ID: 29161895
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter by Bilazarian et al. regarding the article, "Adverse events and modes of failure related to Impella RP: Insights from the Manufacturer and User Facility Device Experience (MAUDE) database" by Khalid et al.
    Bilazarian S; Bolt W
    Cardiovasc Revasc Med; 2019 Jul; 20(7):622. PubMed ID: 31088719
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Giusti et al., Editorial Comment on: Supracostal Upper Pole Endoscopic-Guided Prone Tubeless "Maxi-Percutaneous Nephrolithotomy": A Contemporary Evaluation of Complications by Altschuler et al. (From: Giusti G, Proietti S, and Rodríguez-Socarrás, ME. J Endourol 2019;33:279-280; DOI: 10.1089/end.2018.0856).
    Scarpa RM; Papalia R
    J Endourol; 2019 Apr; 33(4):281-282. PubMed ID: 30760023
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial Comment on: Supracostal Upper Pole Endoscopic-Guided Prone Tubeless "Maxi-Percutaneous Nephrolithotomy": A Contemporary Evaluation of Complications by Altschuler et al. (From: Altschuler J, Jain R, Monga M, J Endourol 2019;33:274-278; DOI: 10.1089/end.2018.0502).
    Giusti G; Proietti S; Rodríguez-Socarrás ME
    J Endourol; 2019 Apr; 33(4):279-280. PubMed ID: 30585740
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial Comment on: Pilot Assessment of Immersive Virtual Reality Renal Models as an Educational and Preoperative Planning Tool for Percutaneous Nephrolithotomy by Parkhomenko et al. (From: Parkhomenko E, O'Leary M, Safiullah S, et al., J Endourol 2019;33:283-288; DOI: 10.1089/end.2018.0626).
    Ghazi A
    J Endourol; 2019 Apr; 33(4):289-290. PubMed ID: 30648429
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Desai JD; Suarez-Ibarrola R
    J Endourol; 2019 Aug; 33(8):639-640. PubMed ID: 31154854
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Aminsharifi A; Silver D; Schulman A
    J Endourol; 2020 Feb; 34(2):242. PubMed ID: 32077767
    [No Abstract]   [Full Text] [Related]  

  • 11.
    El-Nahas AR
    J Endourol; 2020 Jun; 34(6):699-700. PubMed ID: 32204611
    [No Abstract]   [Full Text] [Related]  

  • 12.
    Aminsharifi A
    J Endourol; 2020 Jun; 34(6):700-701. PubMed ID: 32568591
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Outpatient Percutaneous Nephrolithotomy: The UC San Diego Health Experience (From: Bechi SK, Hans DS, Abott JE, et al. J Endourol 2018;32:394-401).
    Kendall MC
    J Endourol; 2018 Aug; 32(8):777. PubMed ID: 29848064
    [No Abstract]   [Full Text] [Related]  

  • 14.
    Babayan RK; Steinberg ML; Miller LE
    J Endourol; 2020 Feb; 34(2):240-241. PubMed ID: 31914809
    [No Abstract]   [Full Text] [Related]  

  • 15. An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh.
    Sandberg JM; Gray I; Pearlman A; Terlecki RP
    Investig Clin Urol; 2018 Mar; 59(2):126-132. PubMed ID: 29520389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of stone baskets: 14-year review of the manufacturer and user facility device experience database.
    Chotikawanich E; Korman E; Monga M
    J Urol; 2011 Jan; 185(1):179-83. PubMed ID: 21074791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Pre- and Post-Operative Predictors of Infection-Related Complications in Patients Undergoing Percutaneous Nephrolithotomy (From: Rivera M, Viers B, Cockerill P, et al. J Endourol 2016;30:982-986).
    Bozkurt IH; Basmaci I; Yonguc T
    J Endourol; 2017 May; 31(5):545. PubMed ID: 27832704
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Randomized Controlled Trial Comparing Three Different Modalities of Lithotrites for Intracorporeal Lithotripsy in Percutaneous Nephrolithotomy (From: York T, Borofsky MS, Chew BH, et al. J Endourol 2017;31:1145-1151).
    Radfar MH; Shakiba B
    J Endourol; 2018 Mar; 32(3):264. PubMed ID: 29310460
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Clinically Insignificant Residual Fragments After Percutaneous Nephrolithotomy: Medium-Term Follow-Up (From: Altunrende F, Tefekli A, Stein RJ, et al. J Endourol 2011;25:941-945).
    Mandal S; Goel A; Kathpalia R
    J Endourol; 2016 Jul; 30(7):831. PubMed ID: 22734836
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse Events Involving Radiation Oncology Medical Devices: Comprehensive Analysis of US Food and Drug Administration Data, 1991 to 2015.
    Connor MJ; Marshall DC; Moiseenko V; Moore K; Cervino L; Atwood T; Sanghvi P; Mundt AJ; Pawlicki T; Recht A; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):18-26. PubMed ID: 27979446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.